Company profile: Kaleo
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical combination drug/device products and auto-injectors, including the Aerio gas-powered auto-injector platform (single, dual container, dual chamber); AUVI-Q and ALLERJECT epinephrine devices for severe allergic reactions; Naloxone Auto-Injector 10 mg for military and chemical incident responders; Pralidoxime Chloride Auto-Injector; and a patient assistance program.
Products and services
- AUVI-Q: Epinephrine-based injection device for emergency treatment of severe allergic reactions, marketed in the United States, empowering patient-controlled use
- Aerio Auto-Injector Platform: Gas-powered auto-injector platform delivering larger-volume, higher-viscosity formulations, available in single container, dual container, and dual chamber versions for combination drug products
- Naloxone Auto-Injector 10 mg: Naloxone hydrochloride injection device for military personnel and chemical incident responders to counteract opioid overdoses
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kaleo
Nurse Assist
HQ: United States
Website
- Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nurse Assist company profile →
Biora Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology as a biotech company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biora Therapeutics company profile →
Fertin Pharma
HQ: Denmark
Website
- Description: Provider of innovative, high-quality pharmaceutical and nutraceutical chewing gum products, partnering with leading global pharma companies as a preferred B2B partner for nicotine chewing gum. Offers Zapliq liquefying tablets, compressed and extruded gums (for nicotine replacement therapy and other applications), lozenges, pouch powder, and custom co-developed delivery systems with controlled release.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fertin Pharma company profile →
NuGen Medical Devices
HQ: Canada
Website
- Description: Provider of needle-free medical delivery technologies, including InsuJet, a spring-loaded injection system for self-administration by patients and healthcare practitioners that delivers drugs through the skin, and PetJet, a device for veterinary use facilitating painless, quick treatment for pets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGen Medical Devices company profile →
Corsair Pharma
HQ: United States
Website
- Description: Provider of a transdermal treprostinil prodrug patch for pulmonary arterial hypertension (PAH), designed to deliver consistent blood levels and reduce the need for invasive administration. Develops transformative solutions to improve the therapeutic profile of medications and provide superior treatment for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corsair Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kaleo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kaleo
2.2 - Growth funds investing in similar companies to Kaleo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kaleo
4.2 - Public trading comparable groups for Kaleo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →